EGFR and non-small cell lung carcinoma: However, this finding is confounded by the fact that a greater proportion of smokers had received EGFR TKI beyond the second and third line setting, and the impact of smoking on survival in EGFR mutation positive NSCLC patients receiving first line EGFR TKI remains unclear [9].